Document Report Card
Basic Information
ID: ALA4043168
Journal: Bioorg Med Chem Lett
Title: The design and SAR of a novel series of 2-aminopyridine based LRRK2 inhibitors.
Authors: Smith GP, Badolo L, Chell V, Chen IJ, Christensen KV, David L, Daechsel JA, Hentzer M, Herzig MC, Mikkelsen GK, Watson SP, Williamson DS.
Abstract: Leucine-rich repeat kinase 2 (LRRK2) has attracted considerable interest as a therapeutic target for the treatment of Parkinson's disease. Compounds derived from a 2-aminopyridine screening hit were optimised using a LRRK2 homology model based on mixed lineage kinase 1 (MLK1), such that a 2-aminopyridine-based lead molecule 45, with in vivo activity, was identified.
CiteXplore: 28802631